Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjectsSTONE, Nimalie D; DUNAWAY, Shelia B; PARK, Jeong-Gun et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2351-2358, issn 0066-4804, 8 p.Article

A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphomaKAUFMAN, Jonathan L; FLOWERS, Christopher R; WALLER, Edmund K et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 1, pp 76-84, issn 0041-1132, 9 p.Article

Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy VolunteersNYUNT, Myaing M; BECKER, Stephen; MACFARLAND, Ron T et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 5, pp 559-565, issn 1525-4135, 7 p.Article